1 A Systematic Review of miR-29 in Cancer

被引:200
作者
Kwon, Jason J. [1 ]
Factora, Tricia D. [1 ]
Dey, Shatovisha [1 ]
Kota, Janaiah [1 ,2 ]
机构
[1] Indiana Univ Sch Med, Dept Med & Mol Genet, 975 West Walnut St,IB 244C, Indianapolis, IN 46202 USA
[2] IUSM, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA
关键词
ACUTE MYELOID-LEUKEMIA; SINGLE-STRANDED RNA; CELL LUNG-CANCER; MICRORNA-29; FAMILY; DNA METHYLTRANSFERASES; OVARIAN-CANCER; MESENCHYMAL TRANSITION; GENE-EXPRESSION; DOWN-REGULATION; BREAST-CANCER;
D O I
10.1016/j.omto.2018.12.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNA) are small non-coding RNAs (similar to 22 nt in length) that are known as potent master regulators of eukaryotic gene expression. miRNAs have been shown to play a critical role in cancer pathogenesis, and the misregulation of miRNAs is a well-known feature of cancer. In recent years, miR-29 has emerged as a critical miRNA in various cancers, and it has been shown to regulate multiple oncogenic processes, including epigenetics, proteostasis, metabolism, proliferation, apoptosis, metastasis, fibrosis, angiogenesis, and immunomodulation. Although miR-29 has been thoroughly documented as a tumor suppressor in the majority of studies, some controversy remains with conflicting reports of miR-29 as an oncogene. In this review, we provide a systematic overview of miR-29's functional role in various mechanisms of cancer and introspection on the contradictory roles of miR-29.
引用
收藏
页码:173 / 194
页数:22
相关论文
共 256 条
[91]   DORMANCY OF MICROMETASTASES - BALANCED PROLIFERATION AND APOPTOSIS IN THE PRESENCE OF ANGIOGENESIS SUPPRESSION [J].
HOLMGREN, L ;
OREILLY, MS ;
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (02) :149-153
[92]   A hexanucleotide element directs microRNA nuclear import [J].
Hwang, Hun-Way ;
Wentzel, Erik A. ;
Mendell, Joshua T. .
SCIENCE, 2007, 315 (5808) :97-100
[93]   Recent advances in apoptosis, mitochondria and drug resistance in cancer cells [J].
Indran, Inthrani R. ;
Tufo, Gregory ;
Pervaiz, Shazib ;
Brenner, Catherine .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2011, 1807 (06) :735-745
[94]   Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine [J].
Ito, Shinsuke ;
Shen, Li ;
Dai, Qing ;
Wu, Susan C. ;
Collins, Leonard B. ;
Swenberg, James A. ;
He, Chuan ;
Zhang, Yi .
SCIENCE, 2011, 333 (6047) :1300-1303
[95]   Analysis of microRNA-target interactions across diverse cancer types [J].
Jacobsen, Anders ;
Silber, Joachim ;
Harinath, Girish ;
Huse, Jason T. ;
Schultz, Nikolaus ;
Sander, Chris .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2013, 20 (11) :1325-U131
[96]   Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer [J].
Jacquemier, Jocelyne ;
Charafe-Jauffret, Emmanuelle ;
Monville, Florence ;
Esterni, Benjamin ;
Extra, Jean Marc ;
Houvenaeghel, Gilles ;
Xerri, Luc ;
Bertucci, Francois ;
Birnbaum, Daniel .
BREAST CANCER RESEARCH, 2009, 11 (02)
[97]   MiR-29b replacement inhibits proteasomes and disrupts aggresome plus autophagosome formation to enhance the antimyeloma benefit of bortezomib [J].
Jagannathan, S. ;
Vad, N. ;
Vallabhapurapu, S. ;
Vallabhapurapu, S. ;
Anderson, K. C. ;
Driscoll, J. J. .
LEUKEMIA, 2015, 29 (03) :727-738
[98]   Nuclear and cytoplasmic localization of neural stem cell microRNAs [J].
Jeffries, Clark D. ;
Fried, Howard M. ;
Perkins, Diana O. .
RNA, 2011, 17 (04) :675-686
[99]   Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05) [J].
Joerger, M. ;
Baty, F. ;
Frueh, M. ;
Droege, C. ;
Stahel, R. A. ;
Betticher, D. C. ;
von Moos, R. ;
Ochsenbein, A. ;
Pless, M. ;
Gautschi, O. ;
Rothschild, S. ;
Brauchli, P. ;
Klingbiel, D. ;
Zappa, F. ;
Brutsche, M. .
LUNG CANCER, 2014, 85 (02) :306-313
[100]  
Jonckheere Nicolas, 2008, Critical Reviews in Oncogenesis, V14, P177